Skip to content
ppharmaranks
Menu

Imciromab Pentetate: uses, dosing, side effects & brands

Imciromab Pentetate is a medicine sold in the U.S. under one brand. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.

By the pharmaranks editorial teamReviewed against the FDA (openFDA label, NDC Directory & Enforcement) sourcesUpdated Jul 24, 2026How we research

Key facts

Available as
Injectable
Sold as
Myoscint
Prescription?
Prescription only
Generic available?
Not in our catalog

Every imciromab pentetate product we track (1)

Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.

Only one: Myoscint.

Related calculators

Frequently asked questions

Can you take imciromab pentetate with other medicines?

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run imciromab pentetate against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

What forms does imciromab pentetate come in?

Across the brands we track, imciromab pentetate is currently marketed as injectable, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Is there a generic imciromab pentetate?

We do not currently list a generic-labelled imciromab pentetate product. That does not always mean none exists — it means none appears under a generic name in the FDA data we track. Ask your pharmacist.

Cite this page
APA
pharmaranks. (2026, July 24). Imciromab Pentetate: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/imciromab-pentetate
MLA
“Imciromab Pentetate: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/imciromab-pentetate.

We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.

Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.

Read the full FDA label for imciromab pentetate on DailyMed (NIH) ↗.